Skip to main content
bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.090
+0.830 (319.23%)
At close: Apr 1, 2025, 4:00 PM
1.310
+0.220 (20.16%)
After-hours: Apr 1, 2025, 7:59 PM EDT

bioAffinity Technologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
--7.94-8.15-6.33-7.27
Depreciation & Amortization
-0.380.0100.02
Other Amortization
--2.060.48-
Stock-Based Compensation
-0.750.250.040.28
Other Operating Activities
--0.131.653.124.28
Change in Accounts Receivable
-0.31-0.01--
Change in Inventory
--0.01-0.01--
Change in Accounts Payable
--0.010.110.040.09
Change in Unearned Revenue
-0.03---
Change in Other Net Operating Assets
-0.580.010.590.39
Operating Cash Flow
--6.04-4.07-2.05-2.21
Capital Expenditures
--0.02-0.22--0
Cash Acquisitions
--2.19---
Investing Cash Flow
--2.21-0.22--0
Short-Term Debt Issued
--0.723.31.48
Long-Term Debt Issued
--0.560.210.24
Total Debt Issued
--1.283.511.72
Long-Term Debt Repaid
--0.34-0.69--
Net Debt Issued (Repaid)
--0.340.583.511.72
Issuance of Common Stock
--13.82--
Repurchase of Common Stock
---0--
Other Financing Activities
---0.06-0.18-
Financing Cash Flow
--0.3414.343.331.72
Net Cash Flow
--8.5910.051.28-0.5
Free Cash Flow
--6.06-4.29-2.05-2.21
Free Cash Flow Margin
--239.32%-89336.50%--
Free Cash Flow Per Share
--0.69-0.95-0.77-0.83
Cash Interest Paid
-0.040.03--
Cash Income Tax Paid
-0.02000
Levered Free Cash Flow
--3.61-3.41-0.85-
Unlevered Free Cash Flow
--3.58-3.89-0.71-
Change in Net Working Capital
-0.18-0.31.42-0.63-
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q